nDatalyze Corp. Announces Termination of Proposed Reverse Takeover with Prism Diversified Ltd. and Provides Epitome Update
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
nDatalyze (NDATF) has delivered notice terminating its proposed reverse takeover with Prism Diversified after the transaction missed its October 31, 2026 deadline. The parties did not agree to an extension. Escrowed subscription proceeds will be returned and subscription receipts cancelled because the financing’s release conditions were not met; no company shares will be issued under the financing.
The shareholder-approved spin-out and name change, both conditional on the takeover, will not proceed at this time. Shares remain halted, and nDatalyze plans to apply for trading reinstatement, subject to CSE review and approval. The company intends to continue commercializing its Epitome sports performance platform, whether privately or publicly.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Financing cancellation means no company shares will be issued under the financing.
- Minor point. Forward-looking: it has not happened yet and may not happen.Epitome commercialization remains a company-stated plan, whether privately or publicly.
Negative
- Moderate pointPrism reverse takeover missed the October 31, 2026 deadline; termination notice has been delivered.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Financing release conditions were not satisfied; escrowed proceeds will be returned and subscription receipts cancelled.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Shares remain halted; planned trading reinstatement requires CSE review and approval.
- Minor point. Forward-looking: it has not happened yet and may not happen.Conditional spin-out and name change will not be implemented at this time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CALGARY, AB – November 4, 2026 - TheNewswire – nDatalyze Corp. (CSE: NDAT) (OTC: NDATF) (the “Company” or “nDatalyze”) announces that the proposed reverse takeover transaction (the “RTO”) with Prism Diversified Ltd. (“Prism”) did not close on or before the October 31, 2026 completion deadline under the business combination agreement dated May 15, 2026 among the Company, Prism and 2273670 Alberta Ltd., as amended September 1, 2026 (the “Business Combination Agreement”), and no extension beyond October 31, 2026 was agreed to by the parties. The Company has delivered notice of termination of the Business Combination Agreement to Prism in accordance with its terms, and reserves all of its rights thereunder.
As the escrow release conditions under the concurrent subscription receipt financing were not satisfied prior to the escrow release deadline, the subscription proceeds held in escrow by Odyssey Trust Company will be returned to subscribers, and the subscription receipts will be cancelled, in each case in accordance with the terms of the subscription receipt agreement. No shares of the Company will be issued under the financing.
The spin-out transaction and name change approved by shareholders at the Company’s special meeting held on October 2, 2026 were conditional on completion of the RTO and will not be implemented at this time.
Trading in the Company’s common shares has been halted since the announcement of the proposed RTO. The Company will be applying to the CSE for reinstatement of trading, which remains subject to the review and approval of the CSE.
Jim Durward, President, states: “It’s unfortunate that the RTO did not close as set out in the Business Combination Agreement and First Amendment. This said, Epitome has always been the Company’s main asset and we intend to move forward with its commercialization, whether private or public. To this end, we will be presenting Epitome at Hockey Inspires Leadership Coach Day in Calgary on November 9, 2026.”
About nDatalyze Corp.
nDatalyze Corp. is a technology company focused on developing health and performance-related solutions through the application of advanced artificial intelligence and biometric data analytics, including the Epitome sports performance platform.
For Further Information, please contact:
Jim Durward, President, CEO/CTO
Email: jimd@ndatalyze.com
Tel: (403) 689-3901
nDatalyze Website: https://www.ndatalyze.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward-looking statements, including statements regarding the return of escrowed subscription proceeds, the reinstatement of trading of the Company’s common shares on the Canadian Securities Exchange and the commercialization of the Epitome platform. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Although the Corporation believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Copyright (c) 2026 TheNewswire - All rights reserved.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did nDatalyze terminate the proposed Prism reverse takeover?
The proposed reverse takeover did not close by the October 31, 2026 completion deadline, and the parties did not agree to an extension. nDatalyze delivered notice terminating the business combination agreement.
What happens to nDatalyze subscription receipt financing after the Prism transaction termination?
Escrowed subscription proceeds will be returned to subscribers, and the subscription receipts will be cancelled under the subscription receipt agreement. The escrow release conditions were not satisfied before the deadline, and no company shares will be issued under the financing.
When will nDatalyze present Epitome following the Prism transaction termination?
nDatalyze plans to present Epitome at Hockey Inspires Leadership Coach Day in Calgary on November 9, 2026.